600 patients66,869 observations120 daysLIVE
← Patients

Patient P-01694

Synthetic patientNBL-101 · Day 110 · 65–74 · M · baseline S18Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 started — Baseline state S18

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability-19
  • Inflammatory activity-10
  • Treatment adherence-7
  • Toxicity+6
  • Nutritional resilience+5

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    17.3/100
    improving · -4.5 vs previous 14 d
    Toxicity
    Blood
    21.2/100
    stable · -0.2 vs previous 14 d
    Sleep quality
    Wearable
    35.6/100
    improving · +3.4 vs previous 14 d
    Energy level
    Daily log
    6/10
    stable · +0.1 vs previous 14 d
    Stress level
    Daily log
    4.1/10
    stable · +0.1 vs previous 14 d
    Steps
    Wearable
    4,126
    improving · +391 vs previous 14 d
    Adherence
    Companion
    89.2 %
    stable · -2.7 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards restoration · 78 from the failing basin, 14 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    Would not help
    • Keep simple carbs low
      GI +3.3 next day on high-intake days · n 13
    • Keep alcohol low
      GI +2.4 next day on high-intake days · n 15
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Simple carbohydrates
      +3.3detractor · 86%
    • Alcohol
      +2.4detractor · 88%
    • Spicy / capsaicin
      +1no signal · 29%
    • Dietary fat load
      -0.8no signal · 22%
    • Histamine load
      +0.4no signal · 15%
    • Insoluble fibre
      +0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production ↓25
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery ↑20
      • WearableShort sleep window
    • Mucosal barrier integrity ↓10
      • WearableSleep 5.8 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.8 · butyrate capacity 76/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    59 ms
    Sleep
    6.1 h
    Steps
    5,065
    Resting HR
    62 bpm
    Daily log: GI score 17, nutritional resilience 63, adherence 89.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0180437%S19AD-05improved61
    P-0137735%S11AD-05no change42
    P-0154135%S09AD-05no change43
    P-0148332%S14AD-05no change35
    P-0167930%S12AD-05no change39
    P-0168936%S13BR-03no change50
    P-0132933%S08BR-03improved79
    P-0146833%S06BR-03no change41
    P-0167733%S05BR-03no change86
    P-0135030%S19BR-03no change34
    P-0143039%S05CR-01improved54
    P-0172453%S10DT-01improved63